Abstract
Malaria represents one of the main public health problems worldwide and continues to be a great challenge to Brazil which concentrates about 34.4% of the disease cases registered in the American continent. Approximately 99% of Malaria cases occur in Amazonia. In 2017, 194,000 cases were recorded. This increase in the number of cases may be a warning of a possible decline in the effectiveness of control and surveillance programs in the region. The objective of this study is to propose the design of interactive visualizations of data related to Malaria Surveillance in the Brazilian Amazon, between the years of 2007-2019. Data came from SIVEPMalaria. We used data visualization techniques to explore epidemiological and demographic aspects of Malaria Surveillance. We hope tools of this kind can reduce the burden of data extraction and analysis on health staff and local policy makers.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We thank the Bill & Melinda Gates Foundation (Process ID INV 003970) and Brazilian Ministry of Health through the National Council for Scientific and Technological Development (CNPq) (Process 443048/2019-3) by financial support.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This work uses data in the public domain, made available upon request for access to information to the Brazilian Ministry of Health, in accordance with Law No. 12,527, of November 18, 2011 (L12527). The data is de-identified, and the results present aggregated information, therefore, this work is exempt from being evaluated by the Ethics and Research Committee, according to Resolution No. 510, of April 7, 2016, of the National Health Council (Resolution CNS/MS 510/16).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Data Availability
SIVEP-Malaria dataset was made available upon request for access to information to the Brazilian Ministry of Health, in accordance with Law No. 12,527, of November 18, 2011 (L12527).
